Journal
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
Volume 82, Issue 10, Pages 824-832Publisher
CANADIAN SCIENCE PUBLISHING
DOI: 10.1139/Y04-064
Keywords
signalling; apoptosis; isoforms; mass spectrometry
Categories
Funding
- NCRR NIH HHS [P41-RR00954] Funding Source: Medline
- NHLBI NIH HHS [P01-HL57278] Funding Source: Medline
- NIDDK NIH HHS [P60-DK20579, R37-DK34388, P30-DK56341] Funding Source: Medline
Ask authors/readers for more resources
Many cells express a Group VIA phospholipase A(2), designated iPLA2(beta), that does not require calcium for activation, is stimulated by ATP, and is sensitive to inhibition by a bromoenol lactone suicide substrate (BEL). Studies in various cell systems have led to the suggestion that iPLA(2)beta has a role in phospholipid remodeling, signal transduction, cell proliferation, and apoptosis. We have found that pancreatic islets, beta-cells, and glucose-responsive insulinoma cells express an iPLA(2)beta that participates in glucose-stimulated insulin secretion but is not involved in membrane phospholipid remodeling. Additionally, recent studies reveal that iPLA(2)beta is involved in pathways that contribute to beta-cell proliferation and apoptosis, and that various phospholipid-derived mediators are involved in these processes. Detailed characterization of the enzyme suggests that the beta-cells express multiple isoforms of iPLA(2)beta, and we hypothesize that these participate in different cellular functions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available